The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we will also feature unique stories and perspectives about the importance of isotopes from current industry leaders. In this episode, CNIC Chair James Scongack is joined by David Harris, President & CEO of Kinectrics, and Dr. Travis Besanger, Senior Business & Technical Director of Medical Isotopes at Kinectrics. Kinectrics and Framatome together form a joint venture called IsoGen that has implemented an Isotope Production System at Bruce Power. The IPS is the world’s first commercial scale source of lutetium-177 produced by a power reactor and the first commercial stable isotope enrichment platform for the production of ytterbium-176 in North America.